Congress:
ECR25
Poster Number:
C-17574
Type:
Poster: EPOS Radiologist (scientific)
Authorblock:
T. Dell, J. A. Luetkens, C. C. Pieper, A. Isaak, P. A. Kupczyk, D. Kütting; Bonn/DE
Disclosures:
Tatjana Dell:
Nothing to disclose
Julian Alexander Luetkens:
Nothing to disclose
Claus Christian Pieper:
Nothing to disclose
Alexander Isaak:
Nothing to disclose
Patrick Arthur Kupczyk:
Nothing to disclose
Daniel Kütting:
Nothing to disclose
Keywords:
Liver, CT-Quantitative, Screening, Cirrhosis
Photon-counting CT (PCCT) allows for accurate estimation of fat fraction in a standard clinical setting, suggesting applications in screening, monitoring, and disease prevention. Further investigation is needed to identify and validate high-sensitivity thresholds, particularly in diverse populations. Prospective multicenter studies are essential to validate PCCT technology as a biomarker for steatosis and establish optimal thresholds for clinical utility and clinical trials.